Company news

Black Diamond Therapeutics, Inc. news in 2024

Black Diamond Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 4, 2024

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

October 6, 2024

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

September 22, 2024

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC

September 21, 2024

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024

September 13, 2024

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

August 5, 2024

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 31, 2024

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 8, 2024

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

April 23, 2024

Black Diamond Therapeutics Announces Changes to Board of Directors

April 10, 2024

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

April 6, 2024

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

March 11, 2024

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

March 4, 2024

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

February 27, 2024

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

January 3, 2024

Decks in 2024